[1] Idzkowska E, Eljaszewicz A, Miklasz P, et al. The role of different monocyte subsets in the pathogenesis of atherosclerosis and acute coronary syndromes[J]. Scand J Immunol, 2015, 82(3):163-173.[2] Ilhan F, Kalkanli ST. Atherosclerosis and the role of immune cells[J]. World J Clin Cases, 2015, 3(4):345-352.[3] Mor A, Luboshits G, Planer D, et al. Altered status of CD4(+)CD25(+) regulatory T cells in patients with acute coronary syndromes[J]. Eur Heart J, 2006, 27(21):2530-2537.[4] Schiro A, Wilkinson FL, Weston R, et al. Endothelial microparticles as conveyors of information in atherosclerotic disease[J]. Atherosclerosis, 2014, 234(2):295-302.[5] Lu Y, Li L, Yan H, et al. Endothelial microparticles exert differential effects on functions of Th1 in patients with acute coronary syndrome[J]. Int J Cardiol, 2013, 168(6):5396-5404.[6] Nijiati M, Gao Y, Abudureheman Z, et al. Relationship between the level of circulating endothelial micro-particles in the blood and blood lipid content in uyghur and Han patients with acute coronary syndrome[J]. Clin Lab, 2015, 61(8):1071-1075.[7] Berezin A, Zulli A, Kerrigan S, et al. Predictive role of circulating endothelial-derived microparticles in cardiovascular diseases[J]. Clin Biochem, 2015, 48(9):562-568.[8] Abbate R, Cioni G, Ricci I, et al. Thrombosis and acute coronary syndrome[J]. Thromb Res, 2012, 129(3):235-240.[9] Altun I, Oz F, Arkaya SC, et al. Effect of statins on endothelial function in patients with acute coronary syndrome:a prospective study using adhesion molecules and flow-mediated dilatation[J]. J Clin Med Res, 2014, 6(5):354-361.[10] Zheng Y, Wang Z, Deng L, et al. Modulation of STAT3 and STAT5 activity rectifies the imbalance of Th17 and Treg cells in patients with acute coronary syndrome[J]. Clin Immunol, 2015, 157(1):65-77.[11] Meng X, Li W, Yang J, et al. Regulatory T cells prevent plaque disruption in apolipoprotein E-knockout mice[J]. Int J Cardiol, 2013, 168(3):2684-2692.[12] Cheng X, Yu X, Ding YJ, et al. The Th17/Treg imbalance in patients with acute coronary syndrome[J]. Clin Immunol, 2008, 127(1):89-97.[13] Han SF, Liu P, Zhang W, et al. The opposite-direction modulation of CD4+CD25+ Tregs and T helper 1 cells in acute coronary syndromes[J]. Clin Immunol, 2007, 124(1):90-97.[14] Ait-Oufella H, Sage AP, Mallat Z, et al. Adaptive (T and B cells) immunity and control by dendritic cells in atherosclerosis[J]. Circ Res, 2014, 114(10):1640-1660.[15] Wang ZX, Wang CQ, Li XY, et al. Changes of naturally occurring CD4(+)CD25(+) FOXP3(+) regulatory T cells in patients with acute coronary syndrome and the beneficial effects of atorvastatin treatment[J]. Int Heart J, 2015, 56(2):163-169. |